HomeNewsIndiaIndia top source of social media misinformation on COVID-19: Study

India top source of social media misinformation on COVID-19: Study

The study, "Prevalence and Source Analysis of COVID-19 Misinformation in 138 Countries", was published in Sage's International Federation of Library Associations and Institutions journal.

September 15, 2021 / 10:44 IST
Story continues below Advertisement
The death toll climbed to 4,42,317 with 308 daily fatalities, according to the data updated at 8 am. (Image: AP)
The death toll climbed to 4,42,317 with 308 daily fatalities, according to the data updated at 8 am. (Image: AP)

India produced the largest amount of social media misinformation on COVID-19 due to the country's higher internet penetration rate, increasing social media consumption and users' lack of internet literacy, according to a new study.

The study, "Prevalence and Source Analysis of COVID-19 Misinformation in 138 Countries", was published in Sage's International Federation of Library Associations and Institutions journal.

Story continues below Advertisement

The study analysed 9,657 pieces of misinformation that originated in 138 countries. They were fact-checked by 94 organisations to understand the prevalence and sources of misinformation in different countries.

"Of all the countries, India (18.07 per cent) produced the largest amount of social media misinformation, perhaps thanks to the country's higher internet penetration rate, increasing social media consumption and users' lack of internet literacy," the study said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show